The Philadelphia-based insurer is the first Blue Cross Blue Shield plan to cover the ConfirmMDx for Prostate Cancer test.
“This positive coverage decision by Independence Blue Cross is a significant milestone as we work toward achieving nationwide payer adoption of our ConfirmMDx for Prostate Cancer test,” said Jan Groen, PhD, CEO of MDxHealth. “This decision demonstrates that our investment in clinical studies and our work with managed care organizations in the U.S. continues to yield positive results.”
More articles about payer issues:
BCBS of Texas commits to offering ACA plans for 2017
House will vote on ACA individual mandate exemption bill
Aetna looks toward social programs for healthcare reform
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
